Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Randomized Study for Treatment of Helicobacter Pylori Infection: 14-day Non-bismuth Quadruple Therapy Versus Triple Therapy.

NCT04769583 is registered in ClinicalTrials.gov with mohamed bouchoucha as lead sponsor.

NCT NCT04769583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04769583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Randomized Study for Treatment of Helicobacter Pylori Infection: 14-day Non-bismuth Quadruple Therapy Versus Triple Therapy.
Lead sponsor
mohamed bouchoucha
Phase
Phase 4
Overall status
Completed
Start date
February 10, 2019
Completion date
March 5, 2020
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastritis h pylori